RetinalGenix Technologies (RTGN) Shares Outstanding (Weighted Average) (2020 - 2026)

RetinalGenix Technologies has disclosed Shares Outstanding (Weighted Average) across 7 years of filings, most recently posting $18.8 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $18.8 million, up 1.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.8 million (up 1.25% YoY), and the FY2025 annual result was $18.6 million, up 3.47% from the prior year.
• Shares Outstanding (Weighted Average) came in at $18.8 million for Q1 2026 at RetinalGenix Technologies, up from $18.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $18.8 million in Q1 2026 to a low of $50000.0 in Q1 2024.
• The 5-year median for Shares Outstanding (Weighted Average) is $17.4 million (2023), against an average of $16.3 million.
• Across the five-year window, Shares Outstanding (Weighted Average) slumped 99.71% in 2024 and surged 36944.59% in 2025, its largest moves.
• RetinalGenix Technologies' Shares Outstanding (Weighted Average) stood at $15.6 million in 2022, then grew by 11.34% to $17.4 million in 2023, then gained by 3.39% to $17.9 million in 2024, then gained by 3.47% to $18.6 million in 2025, then climbed by 1.04% to $18.8 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $18.8 million (Q1 2026), $18.6 million (Q4 2025), and $18.5 million (Q3 2025), per Business Quant data.